Who owns PASITHEA THERAPEUTICS CORP?
- Ticker: KTTA
- CUSIP Number: 70261f202
Tip: Access positions for across all investors
Analyze quarterly positions in Pasithea Therapeutics Corp with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Pasithea Therapeutics Corp stock
Who bought or sold PASITHEA THERAPEUTICS CORP this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Squadron Capital Management | 2.1M | $1.6M | 100% | Mar 2026 |
|
| Adage Capital Partners GP | 2.1M | $2.7M | 100% | Dec 2025 |
|
| Vivo Capital | 2.1M | $1.6M | 0% | Mar 2026 |
|
| Henderson Group | 2.1M | $1.6M | 100% | Mar 2026 |
|
| Ameriprise Financial | 1.4M | $1.0M | -30% | Mar 2026 |
|
| Cable Car Capital | 1.2M | $895k | 141% | Mar 2026 |
|
| AdvisorShares Investments | 338k | $250k | 11% | Mar 2026 |
|
| Persistent Asset Partners | 291k | $216k | 0% | Mar 2026 |
|
| Stonepine Capital Management | 275k | $355k | 100% | Dec 2025 |
|
| Geode Capital Management | 104k | $77k | 91% | Mar 2026 |
|
| Vanguard Group | 98k | $126k | 82% | Dec 2025 |
|
| Vanguard Capital Management | 54k | $40k | 100% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 44k | $33k | 100% | Mar 2026 |
|
| Northern Trust | 28k | $36k | 100% | Dec 2025 |
|
| UBS Group | 26k | $19k | 97% | Mar 2026 |
|
| Two Sigma Investments | 21k | $16k | -57% | Mar 2026 |
|
| XTX Topco | 21k | $27k | -40% | Dec 2025 |
|
| Hurley Capital | 3.7k | $2.7k | 0% | Mar 2026 |
|
| Tower Research Capital | 2.9k | $3.8k | 142% | Dec 2025 |
|
| SBI Securities | 1.1k | $780.052200 | 0% | Mar 2026 |
|
Who sold out of Pasithea Therapeutics Corp?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Longwood Capital Partners | Dec 2025 | 450k | $581k |
| Stempoint Capital | Dec 2025 | 355k | $458k |
| Jane Street | Dec 2025 | 59k | $77k |
| Citadel Advisors | Dec 2025 | 56k | $73k |
| Renaissance Technologies | Sep 2025 | 31k | $23k |
| Virtu Financial | Sep 2025 | 25k | $18k |